Central nervous system tuberculosis after resolution of miliary tuberculosis

Pediatric Infectious Disease Journal

Volumn 17, Issue 6, 1998, Pages 519-523

  Chang, Anne B ^a,c   Grimwood, Keith ^a,b   Harvey, A Simon ^a   Rosenfeld, Jeffrey V ^a   Olinsky, Anthony ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c MATER CHILDREN S HOSPITAL   (Australia)

Author keywords

Child; Corticosteroids; Drug resistance; Miliary tuberculosis; Tuberculoma; Tuberculous meningitis

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLONAZEPAM; DEXAMETHASONE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PREDNISOLONE; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG INDICATION; EYE TOXICITY; HUMAN; INFANT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MILIARY TUBERCULOSIS; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT FAILURE; TUBERCULOUS MENINGITIS;

ANTITUBERCULAR AGENTS; CENTRAL NERVOUS SYSTEM INFECTIONS; DEXAMETHASONE; DRUG THERAPY, COMBINATION; ETHIONAMIDE; GLUCOCORTICOIDS; HUMANS; IMMUNOCOMPETENCE; INFANT; ISONIAZID; MALE; PREDNISOLONE; PYRAZINAMIDE; RIFAMPIN; STREPTOMYCIN; TREATMENT FAILURE; TUBERCULOMA; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, MILIARY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0031833174     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199806000-00019     Document Type: Article

References (29)

1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994;72:213-20.
2. Cantwell MF, Snider DE, Cauthen GM, et al. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994;272:535-9.
3. Freiden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug resistant tuberculosis in New York City. N Engl J Med 1993;328:521-6.
4. Leonard JM, Des Prez RM. Tuberculous meningitis. Infect Dis Clin North Am 1990;4:769-87.
5. Galea P, Goel KM. Tuberculous meningitis in children: a review of 15 cases. Scot Med J 1988;33:205-7.
6. American Thoracic Society official statement. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-74.
7. Donald PR, Parkin DP, Seifart HI, Schoeman JF, van Zyl LE. Drug treatment of tuberculosis meningitis in children. CNS Drugs 1997;6:12-22.
8. Humphries M. The management of tuberculous meningitis. Thorax 1992;47:577-81.
9. Moulding TS. Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance? Am Rev Respir Dis 1981;123:262-4.
10. Jindani A, Aber VR, Edwards EA, et al. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 1980;121:939-49.
11. Notterman DA, Nardi M, Saslow JG. Effect of dose formulation on isoniazid absorption in two young children. Pediatrics 1986;77:850-2.
12. Donald PR, Seifart HI. Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis. J Pediatr 1989;115:483-6.
13. Dawson D. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 1994 and 1995. Commun Dis Intell 1997;21:245-9.
14. Vincken W, Meysman M, Verbeelen D, Lauwers S, D'Haens J. Intraventricular rifampicin in severe tuberculous meningo-enceophalitis. Eur Respir J 1992;5:891-3.
15. Morse ML, Karr DJ, Mendelman PM. Ocular tuberculosis in a five-month-old. Pediatr Infect Dis J 1988;7:514-6.
16. Doerr CA, Starke JR, Ong LT. Clinical and public health aspects of tuberculous meningitis in children. J Pediatr 1995;127:27-33.
17. Campbell IA, Dyson AJ. Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle 1977;58:171-9.
18. Chan HS, Pang JA. Effect of corticosteroids on deterioration of endobronchial tuberculosis during chemotherapy. Chest 1989;96:1195-6.
19. Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994;19:1092-9.
20. Hejazi N, Hassler W. Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy: literature review and a case report. Infection 1997;25:233-9.
21. Inselman LS. Tuberculosis in children: an update. Pediatr Pulmonol 1996;21:101-20.
22. Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997;25:872-87.
23. Newton RW. Tuberculous meningitis. Arch Dis Child 1994; 70:364-6.
24. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997;99:226-31.
25. Stamos JK, Rowley AH. Pediatric tuberculosis: an update. Curr Probl Pediatr 1995;25:131-6.
26. McAllister WAC, Thompson PJ, Al-Habet SM. Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J 1983;286:923-5.
27. Hansten PD. Important drug interactions. In: Katzung BG, ed. Basic and clinical pharmacology. East Norwalk, CT: Appleton & Lange, 1995:986-96.
28. Hill MR, Szefler SJ, Ball BD, Bartoszek M, Brenner AM. Monitoring glucocorticoid therapy: a pharmacokinetic approach. Clin Pharmacol Ther 1990;48:390-8.
29. Brosen K. Recent developments in hepatic drug oxidation: implications for clinical pharmacokinetics. Clin Pharmacokinet 1990;18:220-39.